FOLFOX-Cetuximab/Encorafenib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of leucovorin, fluorouracil and oxaliplatin (FOLFOX) plus cetuximab and encorafenib that is used for the treatment of colorectal cancer, appendiceal cancer, and small bowel adenocarcinoma.

**Synonyms:** - Cetuximab-Encorafenib-FOLFOX - Cetuximab/Encorafenib Plus FOLFOX - Cetuximab/Encorafenib/Fluorouracil/Leucovorin/Oxaliplatin - Encorafenib/Cetuximab Plus FOLFOX - Encorafenib/Cetuximab-FOLFOX - FOLFOX Plus Cetuximab/Encorafenib - FOLFOX Plus Encorafenib/Cetuximab - FOLFOX Plus Erbitux/Braftovi - FOLFOX-Braftovi/Erbitux - FOLFOX-Cetuximab-Encorafenib - FOLFOX-Encorafenib-Cetuximab - FOLFOX-Encorafenib/Cetuximab - FOLFOX/Cetuximab/Encorafenib - FOLFOX/Encorafenib/Cetuximab - Folinic Acid/Fluorouracil/Oxaliplatin/Cetuximab/Encorafenib Regimen - Leucovorin/Fluorouracil/Oxaliplatin/Cetuximab/Encorafenib - Leucovorin/Fluorouracil/Oxaliplatin/Encorafenib/Cetuximab